Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure

被引：2
|
作者：
Ramaraj, Radhakrishnan [1 ]
机构：
[1] Univ Arizona, Coll Med, Dept Internal Med, Tucson, AZ 85721 USA
来源：
HYPERTENSION | 2008年 / 52卷 / 06期
关键词：
D O I：
10.1161/HYPERTENSIONAHA.108.121509
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E147 / E147
页数：1
相关论文
共 50 条
  • [1] Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure Response
    Pitt, Bertram
    HYPERTENSION, 2008, 52 (06) : E148 - E148
  • [2] History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure
    Pitt, Bertram
    Ahmed, Ali
    Love, Thomas E.
    Krum, Henry
    Nicolau, Jose
    Cardoso, Jose S.
    Parkhomenko, Alexander
    Aschermann, Michael
    Corbalan, Ramon
    Solomon, Henry
    Shi, Harry
    Zannad, Faiez
    HYPERTENSION, 2008, 52 (02) : 271 - 278
  • [3] COST-EFFECTIVENESS OF EPLERENONE IN PATIENTS WITH HEART FAILURE AFTER ACUTE MYOCARDIAL INFARCTION
    Marti-Sanchez, D.
    Marti, B.
    Sanchez-Maestre, C.
    VALUE IN HEALTH, 2008, 11 (06) : A394 - A395
  • [4] Efficacy of Intravenous Levosimendan in Patients with Heart Failure Complicated by Acute Myocardial Infarction
    Jia, Zhi
    Guo, Mu
    Zhang, Yun-Qiang
    Liang, Hai-Qing
    Zhang, Li-Yuan
    Song, Yu
    CARDIOLOGY, 2014, 128 (02) : 195 - 201
  • [5] Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure - The National Registry of Myocardial Infarction
    Spencer, FA
    Meyer, TE
    Gore, JM
    Goldberg, RJ
    CIRCULATION, 2002, 105 (22) : 2605 - 2610
  • [6] The EPHESUS trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction
    Pitt, B
    Williams, G
    Remme, W
    Martinez, F
    Lopez-Sendon, J
    Zannad, F
    Neaton, J
    Roniker, B
    Hurley, S
    Burns, D
    Bittman, R
    Kleiman, J
    CARDIOVASCULAR DRUGS AND THERAPY, 2001, 15 (01) : 79 - 87
  • [7] The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction
    Bertram Pitt
    Gordon Williams
    Willem Remme
    Felipe Martinez
    Jose Lopez-Sendon
    Faiez Zannad
    James Neaton
    Barbara Roniker
    Steve Hurley
    Dan Burns
    Richard Bittman
    Jay Kleiman
    Cardiovascular Drugs and Therapy, 2001, 15 : 79 - 87
  • [8] Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study
    Iraqi, Wafae
    Rossignol, Patrick
    Angioi, Michael
    Fay, Renaud
    Nuee, Josette
    Ketelslegers, Jean Marie
    Vincent, John
    Pitt, Bertram
    Zannad, Faiez
    CIRCULATION, 2009, 119 (18) : 2471 - 2479
  • [9] Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure
    Weintraub, WS
    Zhang, ZF
    Mahoney, EM
    Kolm, P
    Spertus, JA
    Caro, J
    Ishak, J
    Goldberg, R
    Tooley, J
    Willke, R
    Pitt, B
    CIRCULATION, 2005, 111 (09) : 1106 - 1113
  • [10] The impact of levosimendan on cerebral hemodynamics in patients with acute myocardial infarction complicated by heart failure
    Lebedeva, N.
    Chesnokova, L.
    Kazachek, Y.
    Tarasov, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 325 - 326
12345